News Snapshot:
KUALA LUMPUR (BLOOMBERG) - Private equity company TPG Capital Asia is considering a plan for an initial public offering of its pathology business in the region, according to people with knowledge of the matter. The buyout firm has asked banks to submit proposals for the potential listing of Pathology Asia Holdings, said the people, who asked not to be named as the process is private. TPG is still weighing a listing venue for the business, while Singapore is among the options, the people said. TPG has expanded the business since it initially bought 39 pathology laboratories from Healthscope in 2018...
